Tom J Harryvan (T J Harryvan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Klebsiella Pneumoniae

Pluripotent Stem Cells

Multidrug Resistant

Top Venues

Cancer gene therapy

The Journal of antimicrobial chemotherapy

International journal of molecular sciences

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Tom J Harryvan, E Schaftenaar, B T Franssens, D C Melles, R J Rentenaar
EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems. The Journal of antimicrobial chemotherapy (2024)
Tom J Harryvan, Marten Visser, Linda de Bruin, Léonie Plug, Lisa Griffioen, Arend Mulder, Peter A van Veelen, Gerbrand J van der Heden van Noort, Marlieke Lm Jongsma, Miranda H Meeuwsen, Emmanuel Jhj Wiertz, Saskia J A M Santegoets, James Ch Hardwick, Thorbald van Hall, Jacques Neefjes, Sjoerd H Van der Burg, Lukas J A C Hawinkels, Elizabeth M E Verdegaal
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. Journal for immunotherapy of cancer 10 (3) (2022)
Tom J Harryvan, Matteo Golo, Nicole Dam, Mark J A Schoonderwoerd, Elham Aida Farshadi, Marten Hornsveld, Wytske M van Weerden, Lukas J A C Hawinkels, Vera Kemp
Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus. Cancer gene therapy (2022)
Tom J Harryvan, Sabine de Lange, Lukas J A C Hawinkels, Elizabeth M E Verdegaal
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells. International journal of molecular sciences 23 (1) (2021)